UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Historical Holders from Q3 2021 to Q2 2025

Symbol
UNCY on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
18,578,488
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 10% $38,405,889 60,961,729 Vivo Opportunity Fund Holdings, L.P. 31 Mar 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $8,370,042 +$1,112,366 13,285,781 +15% RA Capital Management, L.P. 31 Mar 2025
GREAT POINT PARTNERS LLC 10% $7,228,095 11,473,166 Great Point Partners, LLC 31 Dec 2024
Walleye Capital LLC 4.8% $3,150,000 5,000,000 Walleye Capital LLC 31 Dec 2024
Nantahala Capital Partners Limited Partnership 2.8% -62% $1,895,683 -$3,073,653 3,009,021 -62% NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 19 Dec 2024
Nantahala Capital Management, LLC 10% 0% $1,391,993 +$466,046 1,855,991 +50% Nantahala Capital Management, LLC 30 Sep 2025

Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q2 0 $0 -$34,451,479 0
2025 Q1 59,926,848 $34,451,479 -$1,351,595 $0.5749 29
2024 Q4 61,700,962 $49,002,183 +$12,116,344 $0.7942 31
2024 Q3 46,786,564 $19,084,180 +$10,632,565 $0.4079 28
2024 Q2 18,997,259 $9,519,281 -$954,361 $0.5011 23
2024 Q1 14,441,576 $19,929,234 +$6,691,650 $1.38 21
2023 Q4 13,030,671 $11,307,131 -$1,007,258 $0.8677 16
2023 Q3 14,192,814 $12,205,365 +$11,249,090 $0.8600 16
2023 Q2 1,074,486 $1,375,341 -$1,380,929 $1.28 15
2023 Q1 1,686,443 $3,541,351 +$1,994,377 $2.10 13
2022 Q4 795,253 $428,290 -$100,167 $0.5400 9
2022 Q3 968,202 $571,000 -$128,238 $0.5871 11
2022 Q2 1,194,501 $992,000 +$8,181 $0.8335 14
2022 Q1 1,150,630 $1,475,000 +$40,949 $1.28 11
2021 Q4 1,115,406 $2,298,000 -$90,197 $2.06 9
2021 Q3 1,065,645 $3,015,000 +$3,015,000 $2.83 9